Earlier, soluble forms of MCP have been detected in body fluids (Hara et al, 1992) and also in cancer patients' sera that contained increased amounts of the 56 and 47 kDa soluble forms of MCP (Seya et al, 1995). This evidence concerns the gene CD46 and cancer.